FDA inspection
Shiraz Specialty Pharmacy, Inc. dba Axis Pharmacy Northwest: FDA inspection ending Jun 15, 2017
FDA inspection 1014300 · Mountlake Terrace, WA
Key facts
| Inspection ID | 1014300 |
|---|---|
| Firm | Shiraz Specialty Pharmacy, Inc. dba Axis Pharmacy Northwest |
| FEI number | 3013401760 |
| Address | 6007 244th St Sw Ste A1 |
| City | Mountlake Terrace |
| State | WA |
| ZIP | 98043-5427 |
| Fiscal year | 2017 |
| Inspection end date | Jun 15, 2017 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data